Northern Trust’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-10,043
| Closed | -$25K | – | 4364 |
|
|
2020
Q2 | $25K | Buy |
+10,043
| New | +$19K | ﹤0.01% | 4142 |
|
|
2019
Q3 | – | Sell |
-27,601
| Closed | -$265K | – | 4315 |
|
|
2019
Q2 | $265K | Sell |
27,601
-2,391
| -8% | -$44K | ﹤0.01% | 3741 |
|
|
2019
Q1 | $804K | Sell |
29,992
-5,798
| -16% | -$148K | ﹤0.01% | 3428 |
|
|
2018
Q4 | $809K | Sell |
35,790
-15,527
| -30% | -$607K | ﹤0.01% | 3431 |
|
|
2018
Q3 | $2.83M | Sell |
51,317
-1,724
| -3% | -$110K | ﹤0.01% | 3012 |
|
|
2018
Q2 | $3.79M | Buy |
53,041
+1,806
| +4% | +$128K | ﹤0.01% | 2829 |
|
|
2018
Q1 | $3.15M | Buy |
51,235
+419
| +0.8% | +$36.8K | ﹤0.01% | 2851 |
|
|
2017
Q4 | $6.4M | Sell |
50,816
-380
| -0.7% | -$48.7K | ﹤0.01% | 2454 |
|
|
2017
Q3 | $7M | Buy |
51,196
+6,858
| +15% | +$917K | ﹤0.01% | 2418 |
|
|
2017
Q2 | $6.32M | Buy |
44,338
+2,033
| +5% | +$314K | ﹤0.01% | 2470 |
|
|
2017
Q1 | $7.78M | Buy |
42,305
+592
| +1% | +$66.4K | ﹤0.01% | 2292 |
|
|
2016
Q4 | $3.36M | Buy |
41,713
+133
| +0.3% | +$10.5K | ﹤0.01% | 2803 |
|
|
2016
Q3 | $3.19M | Buy |
41,580
+11,202
| +37% | +$897K | ﹤0.01% | 2809 |
|
|
2016
Q2 | $2.61M | Buy |
30,378
+9,270
| +44% | +$849K | ﹤0.01% | 2888 |
|
|
2016
Q1 | $1.95M | Sell |
21,108
-2,041
| -9% | -$204K | ﹤0.01% | 3002 |
|
|
2015
Q4 | $4.64M | Buy |
23,149
+815
| +4% | +$163K | ﹤0.01% | 2501 |
|
|
2015
Q3 | $3.33M | Buy |
22,334
+3,188
| +17% | +$2.34M | ﹤0.01% | 2722 |
|
|
2015
Q2 | $18.2M | Buy |
19,146
+3,235
| +20% | +$2.65M | 0.01% | 1665 |
|
|
2015
Q1 | $11.7M | Buy |
15,911
+1,522
| +11% | +$1.14M | ﹤0.01% | 1976 |
|
|
2014
Q4 | $11.4M | Buy |
14,389
+3,106
| +28% | +$1.67M | ﹤0.01% | 1967 |
|
|
2014
Q3 | $4.5M | Buy |
11,283
+3,291
| +41% | +$881K | ﹤0.01% | 2572 |
|
|
2014
Q2 | $2.16M | Sell |
7,992
-907
| -10% | -$195K | ﹤0.01% | 3048 |
|
|
2014
Q1 | $1.94M | Sell |
8,899
-895
| -9% | -$249K | ﹤0.01% | 3153 |
|
|
2013
Q4 | $2.65M | Buy |
9,794
+2,787
| +40% | +$664K | ﹤0.01% | 2983 |
|
|
2013
Q3 | $1.59M | Buy |
7,007
+5,291
| +308% | +$924K | ﹤0.01% | 3190 |
|
|
2013
Q2 | $241K | Buy |
+1,716
| New | +$272K | ﹤0.01% | 3622 |
|
Northern Trust's TTPH Position: Q3 2020 in Review
Northern Trust sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2020, closing a stake of 10,043 shares — an estimated $25K sold.
Northern Trust first reported a position in TTPH in Q2 2013 and held it in 26 quarters. The position peaked at $18.2M in Q2 2015. 1 fund tracked by Wall St. Rank holds TTPH as of Q3 2020.
- Northern Trust reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
- Northern Trust sold 10,043 Tetraphase Pharmaceuticals, Inc. shares in Q3 2020, an estimated $25K.
- Northern Trust first reported a position in Tetraphase Pharmaceuticals, Inc. in Q2 2013 and held it in 26 quarters.
- Northern Trust's Tetraphase Pharmaceuticals, Inc. position peaked at $18.2M in Q2 2015.
- 1 fund tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2020.
Based on Northern Trust's 13F filing for Q3 2020, filed 16 Nov 2020.